Literature DB >> 8170502

Possible involvement of L-arginine-nitric oxide pathway in modulating regional blood flow to brown adipose tissue of rats.

Y Uchida1, F Tsukahara, K Irie, T Nomoto, T Muraki.   

Abstract

To evaluate whether the L-arginine-nitric oxide (NO) pathway is involved in the regulation of regional blood flow to brown adipose tissue (BAT), the effects of two specific NO synthase inhibitors, NG-nitro-L-arginine methyl ester (L-NAME) and NG-monomethyl-L-arginine (L-NMMA), on the blood flow to interscapular brown adipose tissue (IBAT) were studied in urethane-anesthetized rats. Regional blood flow in IBAT was measured with laser-Doppler flowmetry. An intravenous injection of L-NAME and L-NMMA, but not of either D-enantiomer, caused a transient and dose-dependent increase in IBAT blood flow. Dose-response curves for these NO synthase inhibitors showed that L-NAME was more potent than L-NMMA in increasing IBAT blood flow. We also observed a concomitant pressor effect accompanied by a slight decrease in heart rate following intravenous injection of L-NAME and L-NMMA. An elevation of IBAT blood flow and blood pressure induced by both L-NAME and L-NMMA was reversed by L-arginine in an enantiomerically specific manner. The increase in IBAT blood flow induced by NO synthase inhibitors was of shorter duration and less sensitive to L-arginine than the increase in blood pressure. Our results show that the IBAT blood flow is increased by inhibition of NO synthase and that the response of IBAT vasculature to NO synthase inhibitors is different from that of the resistance vessels which regulate blood pressure. The involvement of L-arginine-NO pathways in modulating microcirculation in IBAT is suggested.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170502     DOI: 10.1007/bf00169836

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  32 in total

1.  Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man.

Authors:  P Vallance; J Collier; S Moncada
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

2.  L-arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation.

Authors:  M E Gold; K S Wood; G M Buga; R E Byrns; L J Ignarro
Journal:  Biochem Biophys Res Commun       Date:  1989-06-15       Impact factor: 3.575

3.  Heterogeneous microvascular coronary alpha-adrenergic vasoconstriction.

Authors:  W M Chilian; S M Layne; C L Eastham; M L Marcus
Journal:  Circ Res       Date:  1989-02       Impact factor: 17.367

4.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

5.  Different activation of the endothelial L-arginine and cyclooxygenase pathway in the human internal mammary artery and saphenous vein.

Authors:  Z H Yang; L von Segesser; E Bauer; P Stulz; M Turina; T F Lüscher
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

6.  NG-monomethyl-L-arginine paradoxically relaxes preconstricted canine intrapulmonary arteries.

Authors:  C M Tseng; L W Goodman; L J Rubin; M L Tod
Journal:  J Appl Physiol (1985)       Date:  1993-02

7.  Haemodynamic responses to NG-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Authors:  J R Fozard; M L Part
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

8.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

9.  Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.

Authors:  M Hecker; J A Mitchell; H J Harris; M Katsura; C Thiemermann; J R Vane
Journal:  Biochem Biophys Res Commun       Date:  1990-03-30       Impact factor: 3.575

10.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

Authors:  R M Palmer; D D Rees; D S Ashton; S Moncada
Journal:  Biochem Biophys Res Commun       Date:  1988-06-30       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.